Research at Liaison Medicare Pharmaceuticals

At Liaison Medicare Pharmaceuticals, we strive to pioneer advancements in healthcare through our robust and innovative research programs. Our dedicated team of scientists and researchers work tirelessly, seeking to uncover the next breakthrough in pharmaceuticals that can significantly improve human health and well-being.

Our Focus

We focus on various areas of pharmaceutical research, including drug discovery, formulation development, clinical trials, and post-market surveillance. Our multi-disciplinary approach ensures that we are at the forefront of medical innovation, consistently seeking to develop treatments and therapies that can address the most pressing health concerns of our time.

Drug Discovery and Development

The journey of a medicine from a mere concept to a life-changing solution is a complex process. At Liaison, we are involved in every step of this journey. Our drug discovery and development process is focused on understanding the biology of diseases, identifying potential therapeutic targets, and designing and synthesizing molecules that can modulate these targets.

Clinical Trials

Clinical trials are a critical aspect of our research process. They allow us to assess the safety and efficacy of our drugs in human subjects. We adhere to the highest ethical standards and international guidelines in conducting our clinical trials, ensuring that the rights and well-being of our participants are protected at all times.

Post-market Surveillance

After a drug is approved and in the market, we continue our research through post-market surveillance. This allows us to monitor the long-term effects and effectiveness of our drugs in a larger population, and ensures the safety and efficacy of our products.

Collaboration

We believe that collaboration fuels innovation. That’s why we have established partnerships with academic institutions, healthcare organizations, and research entities around the world. These collaborations allow us to leverage diverse expertise and resources, further enhancing our research capabilities.

Join Us in Advancing Healthcare

We are more than just a pharmaceutical company; we are a team of problem solvers committed to making a significant difference in the world of healthcare. Join us on this journey as we continue to innovate, research, and transform lives.

Our Products

1. Lycometra™: Lycometra™ is our revolutionary new drug being developed to combat the effects of Type-2 Diabetes. By harnessing the regenerative properties of specialized protein strands, it is designed to repair insulin-producing beta cells in the pancreas, restoring their function and potentially minimizing the need for insulin injection.
2. Revitacilin™: Currently in its Phase II clinical trials, Revitacilin™ shows promising results in treating patients with Alzheimer’s disease. It works by preventing the formation of neurofibrillary tangles and beta-amyloid plaques, two main pathological hallmarks of Alzheimer’s disease. Our research anticipates a significant slowdown in the progression of the disease and improved cognitive functions in patients.
3. CardiaPro™: CardiaPro™ is an innovative biologic drug aimed at reducing the incidence of heart attacks in high-risk patients. It targets the underlying inflammation involved in atherosclerosis, potentially leading to plaque stability and decreased cardiovascular events.
4. Zythrosa™: Zythrosa™ is a next-generation antibiotic currently undergoing Phase III trials. It demonstrates excellent activity against multi-drug resistant bacteria, including MRSA, promising a new weapon in the battle against antibiotic resistance.